InMed Pharmaceuticals Inc (INM)

2.500
-0.220(-8.09%)
  • Volume:
    57,024
  • Bid/Ask:
    2.500/2.590
  • Day's Range:
    2.500 - 2.870

INM Overview

Prev. Close
2.72
Day's Range
2.5-2.87
Revenue
-
Open
2.76
52 wk Range
2.38-8.94
EPS
-1.41
Volume
57,024
Market Cap
40.26M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
-
P/E Ratio
-
Beta
1.46
1-Year Change
-41.77%
Shares Outstanding
8,050,707
Next Earnings Date
Sep 15, 2021
What is your sentiment on InMed Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

InMed Pharmaceuticals Inc News

InMed Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

InMed Pharmaceuticals Inc Company Profile

InMed Pharmaceuticals Inc Company Profile

Employees
11
Market
Canada

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company’s lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.

Read More
  • There are different methods of breaking down and seperating thc cbd thz etc they use a e coli method of bio synthsis other methods are available university of berkley has alot going on and being researh funded by all the big names . Definatly worth a buy i did three buy and sells over the early years here from .25 sell at 1.50 35 sell at 165 and hilding currently ar 30 cents
    0
    • Strictly medicine based cannibus company with no intent on using marijuana with thc, company on the brink of helping several debilitating diseases such as breast cancer, pains like arthritis and disorders such as ptsd.
      0
      • This is the future of pharmaceuticals! Will someone post on inmed?
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.